United Kingdom · Biotechnology startup
United Kingdom · Karus Therapeutics
Karus Therapeutics is a pharmaceutical research company that develops drugs to treat cancer and heart diseases.
Funding reportedLast round: Series B
What company datasets say Karus Therapeutics raised
Funding, as reported
Reported in all14.8Min the source's currency
Rounds7
Last roundSeries B
Last round dateMay 2016
Investors listed8
The company, in detail
What they build
Known for
biotechnologylife sciences
- Sector
- Biotechnology
- Region
- England
- Revenue
- 10M a year, as listed
- Full record
- Every detail in the company directory
Biotechnology in United Kingdom
Startups like it
CellCentricSaffron Walden · founded 2004Raised
Oxford BioTherapeuticsOxford · founded 2004Raised
Chroma TherapeuticsMilton · founded 2020- OxagenAbingdon · founded 1996
RQ Biotechnology Ltd.London · founded 2022
ONIOxford · founded 2016
OxularOxford · founded 2014
Maxion TherapeuticsCambridge · founded 2020
Is this your company?
Add your raise, your deck and your story, and put Karus Therapeutics in front of investors. Or tell us what we have wrong.